Text-message support to help new NHS hearing aid users keep using their hearing aids
Official title: Audiology Text-Messaging Intervention (Florence) to Improve Hearing Aid Use in NHS Adult Audiology Patients: A Feasibility Study With Proof-of-Concept and Embedded Process Evaluation
Run by Wsaud A/s · NCT07146607 · Data updated 2026-11-12
This trial will test whether sending standardised NHS text messages to adults starting hearing aids helps them use their devices more regularly.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Wsaud A/s Industry-sponsored |
| Locations | 3 sites (Nottingham, Nottinghamshire and 2 other locations) |
| Status | Recruiting |
| Started | September 30, 2025 |
| Main results expected | November 2026 |
| Study ends | December 2026 |
| Registry record updated | March 9, 2026 |
| Trial ID | NCT07146607 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) newly prescribed their first NHS acoustic hearing aid who can read English, provide consent, and have access to a mobile phone are ideal candidates.
✕Probably not a fit
People already enrolled on an existing Florence protocol, those without access to a mobile phone, non-English readers, or not first-time hearing aid users are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a UK pilot randomized feasibility trial comparing a Florence-delivered audiology text-message protocol to usual care for new NHS hearing aid users, with 60 participants randomized 1:1. The intervention group will receive a standardised sequence of supportive and behaviour-change text messages between appointments while the control group receives usual audiology follow-up. Primary outcomes focus on trial feasibility, with secondary measures exploring proof-of-concept effects on hearing-aid adherence, patient-reported outcomes, and cost-effectiveness, and a nested process evaluation will interview patients and clinicians. Participants must be adults prescribed their first NHS acoustic hearing aid, have access to a mobile phone, and be able to read English.
Why it matters
Potential benefit: If successful, the texting protocol could increase hearing-aid use, improve quality of life, and reduce wasted NHS resources.
How similar studies have gone: Florence and other text-message interventions have improved self-management in conditions like hypertension, diabetes, and cancer, but applying this approach to audiology is novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
WP1: Pilot Feasibility Study (n=60, 30 per group intervention/control (treatment as usual)) Inclusion criteria * Aged ≥18 years (no upper age limit) * Prescribed their first NHS acoustic hearing aid(s) for the primary concern of hearing loss * Able and willing to provide informed consent * Not currently participating in similar research * Access to a mobile device (This is not required to be a smart phone device) Exclusion criteria * Registered on a pre-existing Florence text-messaging protocol. * Unable to read/understand English WP2: Nested Process Evaluation (minimum n=10 patients, n=2 clinicians) Inclusion criteria (patients) * Aged ≥18 years (no upper age limit) * Prescribed their first NHS acoustic hearing aid(s) for the primary concern of hearing loss * Able and willing to provide informed consent Exclusion criteria (patients) * Registered on a pre-existing Florence text-messaging protocol. * Unable to read/understand English Inclusion criteria (clinicians) * Aged ≥18 years (no upper age limit) * Able and willing to provide informed consent Exclusion criteria (clinicians) • Not meeting criteria for inclusion
Where it's running
-
Sunderland Royal Hospital, Kayll Road, Sunderland, SR4 7TP
Sunderland, United Kingdom Recruiting -
Audiology Department Suite 2 Thomas Linacre Centre Parsons Walk Wigan WN1 1RU
Wigan, United Kingdom Recruiting -
QMC Ropewalk House
Nottingham, Nottinghamshire, United Kingdom Enrolling by invitation
Study contacts
- Principal investigator: Emma E Broome, PhD — University of Nottingham
- Study coordinator: Emma E Broome, PhD
- Email: emma.broome1@nottingham.ac.uk
- Phone: +44 (0) 115 8232606
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
WhatsApp AI support vs paper support for first-time hearing aid users
This study tests whether a WhatsApp-based AI support program helps adults with new hearing aids in LMIC communities use and feel confident about their devices better than a paper pamphlet.
-
Hearing and Brain Development in Children and Teens
This observational study tests how hearing care paths (like hearing aids, cochlear implants, brainstem implants, gene therapy, or no intervention) relate to hearing, speech, language, and brain development in kids and teens, with a normal-hearing group for comparison.
-
Web-based auditory training with easy versus hard task settings to improve speech and listening
This project will test whether easy or hard versions of a web-based auditory training program help adults with hearing loss improve speech understanding and everyday listening.
-
Long-term hearing and speech outcomes after cochlear implants
This project will see if cochlear implants improve hearing, speech understanding, and quality of life in Mandarin-speaking patients of all ages before and after surgery.
-
Clemastine plus engineered sound to improve hearing in noisy environments for age-related central auditory processing disorder
This trial will test whether taking clemastine while listening to engineered sounds helps people aged 45–65 with age-related central auditory processing disorder hear better in noisy places.
-
Add Pedmark to cisplatin chemotherapy to prevent hearing loss in men with stage II–III metastatic testicular germ cell tumors
We will test whether adding Pedmark to cisplatin chemotherapy reduces hearing damage in men with stage II–III metastatic testicular germ cell tumors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.